IPOs Next Week: The primary market witnessed some major listings in both main board and small- and medium-sized enterprise (SME) segments in June, which kept investors engaged with subscriptions and listings. Moving on, the first week of July sees strong market buzz – similarly packed with new listings and initial public offering (IPO) issues, that are available for subscription.
‘’The primary market is gearing up for another stellar period as three companies launch their initial public offerings (IPOs) to raise approximately ₹2,208 crore this week. With political stability restored, stock markets are once again on the rise, and the Nifty and Sensex indices have hit record highs,” said Mahavir Lunawat, Managing Director, Pantomath Capital Advisors Pvt. Ltd, a mid-market investment bank.
Among the ongoing issues, Nephro Care India IPO will close for bidding on July 2. Let’s take a look at some of the companies that are opening for subscription this week and the ones that are getting listed on the bourses.
Emcure Pharma IPO
The mainboard IPO opens for subscription on July 3, 2024 and closes on July 5, 2024. Emcure Pharma IPO is a book built issue of ₹1,952.03 crores. The issue is a combination of fresh issue of 0.79 crore shares aggregating to ₹800.00 crore and offer for sale of 1.14 crore shares aggregating to ₹1,152.03 crore.
Bansal Wire IPO
The mainboard IPO opens for subscription on July 3, 2024 and closes on July 5, 2024. Bansal Wire IPO is a book built issue of ₹745.00 crore. The issue is entirely a fresh issue of 2.91 crore shares.
Ambey Laboratories IPO
The SME IPO opens for subscription on July 4, 2024 and closes on July 8, 2024. Ambey Laboratories IPO is a book built issue of ₹44.68 crore. The issue is a combination of fresh issue of 62.58 lakh shares aggregating to ₹42.55 crore and offer for sale of 3.12 lakh shares aggregating to ₹2.12 crore.
